James A. Bolognese

Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial

Robert S. Bresalier, Robert S. Sandler, Hui Quan et al. · New England Journal of Medicine · 2005 · 2.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

Christopher P. Cannon, Sean Curtis, Garret A. FitzGerald et al. · The Lancet · 2006 · 521 citations

Medicine, Clinical Sciences, Pharmacotherapy +12

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis

Loren Laine, S. E. Harper, Thomas Simon et al. · Gastroenterology · 1999 · 476 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis.

Elliot Ehrich, David J. Watson, James A. Bolognese et al. · PubMed · 2000 · 433 citations

Medicine, Orthopaedic Surgery, Pharmacotherapy +17

A Randomized Trial of Rofecoxib for the Chemoprevention of Colorectal Adenomas

John A. Baron, Robert S. Sandler, Robert S. Bresalier et al. · Gastroenterology · 2006 · 432 citations · Full text

Medicine, Pharmacotherapy, Gastroenterology +6